157 related articles for article (PubMed ID: 35785157)
1. A Nomogram to Predict Survival in Patients With Locoregional Recurrent Nasopharyngeal Carcinoma Receiving Comprehensive Treatment.
Wei YH; Wang Y; Li H; Wang CJ; Liu SR; Huang ZL; Wang GN; Tao YL; Xia YF
Front Oncol; 2022; 12():892510. PubMed ID: 35785157
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a prognostic nomogram to identify optimal candidates for local treatment among patients with local recurrent nasopharyngeal carcinoma.
Sun XS; Liang YJ; Jia GD; Liu SL; Liu LT; Guo SS; Sun R; Luo DH; Chen QY; Tang LQ; Mai HQ
Oral Oncol; 2020 Jul; 106():104711. PubMed ID: 32298996
[TBL] [Abstract][Full Text] [Related]
3. Development of a Comorbidity-Based Nomogram to Predict Survival After Salvage Reirradiation of Locally Recurrent Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era.
Huang RD; Sun Z; Wang XH; Tian YM; Peng YL; Wang JY; Xiao WW; Chen CY; Deng XW; Han F
Front Oncol; 2020; 10():625184. PubMed ID: 33552995
[TBL] [Abstract][Full Text] [Related]
4. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
6. A novel nomogram to predict survival in patients with recurrent nasopharyngeal carcinoma after salvage endoscopic surgery.
Li W; Lu H; Liu J; Liu Q; Wang H; Zhang H; Hu L; Zhao W; Gu Y; Li H; Sun X; Wang D
Oral Oncol; 2020 Dec; 111():104922. PubMed ID: 32712576
[TBL] [Abstract][Full Text] [Related]
7. The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma.
Sun L; Jin Y; Hu W; Zhang M; Jin B; Xu H; Du S; Xu Y; Zhao H; Lu X; Sang X; Zhong S; Yang H; Mao Y
Front Oncol; 2020; 10():554521. PubMed ID: 33194617
[No Abstract] [Full Text] [Related]
8. Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection.
Lu Z; Yan W; Liang J; Yu M; Liu J; Hao J; Wan Q; Liu J; Luo C; Chen Y
Front Oncol; 2020; 10():341. PubMed ID: 32219070
[No Abstract] [Full Text] [Related]
9. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.
Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y
Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
11. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma.
He Y; Liu H; Wang S; Chen Y
PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723
[TBL] [Abstract][Full Text] [Related]
12. Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma.
Lin DF; Li HL; Liu T; Lv XF; Xie CM; Ou XM; Guan J; Zhang Y; Yan WB; He ML; Mao MY; Zhao X; Zhong LZ; Chen WH; Chen QY; Mai HQ; Peng RJ; Tian J; Tang LQ; Dong D
J Natl Cancer Inst; 2024 Apr; ():. PubMed ID: 38637942
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of systemic immune-inflammation index-based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation.
Xin Y; Yang Y; Liu N; Chen Y; Wang Y; Zhang X; Li X; Zhou X
J Gastrointest Oncol; 2021 Apr; 12(2):735-750. PubMed ID: 34012662
[TBL] [Abstract][Full Text] [Related]
14. A novel nomogram with preferable capability in predicting the overall survival of patients after radical esophageal cancer resection based on accessible clinical indicators: A comparison with AJCC staging.
Li X; Xu J; Zhu L; Yang S; Yu L; Lv W; Hu J
Cancer Med; 2021 Jul; 10(13):4228-4239. PubMed ID: 34128338
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
Li H; Wang Z; Yang F; Wang J
J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
[TBL] [Abstract][Full Text] [Related]
16. Nomogram-Integrated C-Reactive Protein/Albumin Ratio Predicts Efficacy And Prognosis In Patients With Thoracic Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy.
Zhang H; Guo XW; Yin XX; Liu YC; Ji SJ
Cancer Manag Res; 2019; 11():9459-9468. PubMed ID: 31819611
[TBL] [Abstract][Full Text] [Related]
17. Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer.
Deng J; Ren Z; Wen J; Wang B; Hou X; Xue Z; Chu X
Cancer Manag Res; 2018; 10():6143-6156. PubMed ID: 30538562
[TBL] [Abstract][Full Text] [Related]
18. Establishment and validation of a nomogram for predicting the benefit of concurrent chemotherapy in stage II nasopharyngeal carcinoma: A study based on a phase III randomized clinical trial with 10-year follow-up.
Sun XS; Li XY; Xiao BB; Liu SL; Chen QY; Tang LQ; Mai HQ
Oral Oncol; 2020 Jan; 100():104490. PubMed ID: 31790913
[TBL] [Abstract][Full Text] [Related]
19. Development and external validation of a nomogram for predicting the overall survival of patients with stage II nasopharyngeal carcinoma after curative treatment.
He SS; Wang CT; Peng ZW; Ren YF; Lu LX; Chen RW; Liang SB; Wang Y; Chen Y
Cancer Manag Res; 2019; 11():4403-4412. PubMed ID: 31191003
[No Abstract] [Full Text] [Related]
20. An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study.
Li XH; Chang H; Xu BQ; Tao YL; Gao J; Chen C; Qu C; Zhou S; Liu SR; Wang XH; Zhang WW; Yang X; Zhou SL; Xia YF
Cancer Med; 2017 Jan; 6(1):310-319. PubMed ID: 27860387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
